CMA expands probe of pharmaceutical sector
The UK’s antitrust agency last week opened three more investigations into alleged anticompetitive agreements in the pharmaceutical sector, expanding the agency’s already extensive probe of the market.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.